222 related articles for article (PubMed ID: 35966596)
1. RNA
Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
[TBL] [Abstract][Full Text] [Related]
2. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
3. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells.
Taylor MA; Davuluri G; Parvani JG; Schiemann BJ; Wendt MK; Plow EF; Schiemann WP; Sossey-Alaoui K
Breast Cancer Res Treat; 2013 Nov; 142(2):341-53. PubMed ID: 24197660
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
5. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
6. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
7. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
Huang CC; Huang MS; Chung HJ; Chiu SY; Yadav P; Lin Y; Liu F; Matsuura I
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3664-3671. PubMed ID: 30251686
[TBL] [Abstract][Full Text] [Related]
8. m
Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
[TBL] [Abstract][Full Text] [Related]
9. Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway.
Kang E; Kim K; Jeon SY; Jung JG; Kim HK; Lee HB; Han W
Cancer Gene Ther; 2022 Aug; 29(8-9):1168-1180. PubMed ID: 35046528
[TBL] [Abstract][Full Text] [Related]
10. The RNA Binding Proteins YTHDC1 and FMRP Regulate the Nuclear Export of
Kim GW; Imam H; Siddiqui A
J Virol; 2021 Jun; 95(13):e0009721. PubMed ID: 33883220
[TBL] [Abstract][Full Text] [Related]
11. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells.
Boudreau HE; Casterline BW; Rada B; Korzeniowska A; Leto TL
Free Radic Biol Med; 2012 Oct; 53(7):1489-99. PubMed ID: 22728268
[TBL] [Abstract][Full Text] [Related]
12. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
[TBL] [Abstract][Full Text] [Related]
13. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
15. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
[TBL] [Abstract][Full Text] [Related]
16. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT
FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C
Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer.
Hao Y; Yang X; Zhang D; Luo J; Chen R
Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085
[TBL] [Abstract][Full Text] [Related]
20. Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent.
Hedrick E; Safe S
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
